SD

Stefan Dengl

Hoffmann-La Roche: 27 patents #105 of 3,238Top 4%
Overall (All Time): #141,700 of 4,157,543Top 4%
27
Patents All Time

Issued Patents All Time

Showing 25 most recent of 27 patents

Patent #TitleCo-InventorsDate
12297290 Method for generating multispecific antibodies from monospecific antibodies Ulrich Brinkmann, Guy Georges, Eike Hoffmann, Klaus Mayer, Felix Bormann 2025-05-13
12297263 Humanized anti-Tau(PS422) antibodies and methods of use Thomas Emrich, Guy Georges, Ulrich Goepfert, Fiona Grueninger, Adrian Hugenmatter +9 more 2025-05-13
12258371 Stabilized immunoglobulin domains Laura Deak Codarri, Jens Fischer, Thomas Hofer, Laurent Lariviere, Ekkehard Moessner +3 more 2025-03-25
12252533 Anti-transferrin receptor antibodies with tailored affinity Guy Georges, Ulrich Goepfert, Jens Niewoehner, Tilman Schlothauer 2025-03-18
12157770 Anti-HLA-G antibodies and methods of use thereof Sebastian Fenn, Jens Fischer, Andreas Hinz, Claudia KIRSTENPFAD, Stefan Klostermann +5 more 2024-12-03
12023378 Covalently linked antigen-antibody conjugates Joerg Benz, Ulrich Brinkmann, Sebastian Dziadek, Guy Georges, Michael Grote +2 more 2024-07-02
11981737 Anti-HLA-G antibodies and use thereof Jens Fischer, Meher MAJETY, Georg Tiefenthaler, Stefan Klostermann, Claudia KIRSTENPFAD +2 more 2024-05-14
11866490 Antibody that binds to VEGF and IL-1beta and methods of use Roland Beckmann, Joerg Benz, Christian Gassner, Guido Hartmann, Peter Michael Huelsmann +6 more 2024-01-09
11827711 Antibodies binding to NKG2D Guy Georges, Ralf Hosse, Inja Waldhauer, Christian Klein, Pablo Umana 2023-11-28
11820816 Anti-VEGF antibodies and methods of use Sebastian Fenn, Guy Georges, Joerg Moelleken, Francesca ROS, Esther Koenigsberger 2023-11-21
11584793 Anti-transferrin receptor antibodies with tailored affinity Guy Georges, Ulrich Goepfert, Jens Niewoehner, Tilman Schlothauer 2023-02-21
11572404 Humanized anti-Tau(pS422) antibodies and methods of use Thomas Emrich, Guy Georges, Ulrich Goepfert, Fiona Grueninger, Adrian Hugenmatter +9 more 2023-02-07
11254728 Method for producing monomeric and multimeric molecules and uses thereof Johannes Auer, Martin Bader, Stefan Lorenz, Stefan Seeber 2022-02-22
11130804 Antibody that binds to VEGF and IL-1beta and methods of use Roland Beckmann, Joerg Benz, Christian Gassner, Guido Hartmann, Peter Michael Huelsmann +6 more 2021-09-28
10822402 Humanized anti-tau(pS422) antibodies and methods of use Thomas Emrich, Guy Georges, Ulrich Goepfert, Fiona Grueninger, Adrian Hugenmatter +9 more 2020-11-03
10808038 HER3/HER2 bispecific antibodies binding to the beta-hairpin of HER3 and domain II of HER2 Birgit Bossenmaier, Richard Buick, Michael Gerg, Carmen Peess, Wolfgang Schaefer +2 more 2020-10-20
10730938 Bispecific antibodies and methods of use in ophthalmology Marc Bedoucha, Sebastian Breuer, Christian Gassner, Guy Georges, Sabine Gruener +9 more 2020-08-04
10570188 Method for producing monomeric and multimeric molecules and uses thereof Johannes Auer, Martin Bader, Stefan Lorenz, Stefan Seeber 2020-02-25
10538585 Anti-ANG2 antibodies and methods of use Guy Georges, Peter Michael Huelsmann, Hubert Kettenberger, Joerg Moelleken, Michael Molhoj +1 more 2020-01-21
10519249 Covalently linked polypeptide toxin-antibody conjugates Ulrich Brinkmann, Eike Hoffmann, Klaus Mayer 2019-12-31
10517945 Covalently linked antigen-antibody conjugates Joerg Benz, Ulrich Brinkmann, Sebastian Dziadek, Guy Georges, Michael Grote +2 more 2019-12-31
10434184 Anti-TPBG antibodies and methods of use Sebastian Fenn, Jens Fischer, Thomas Friess, Sabine Imhof-Jung, Ben-Fillippo KRIPPENDORFF +5 more 2019-10-08
10407511 Covalently linked helicar-anti-helicar antibody conjugates and uses thereof Ulrich Brinkmann, Guy Georges, Eike Hoffmann, Georg Tiefenthaler, Ekkehard Moessner +1 more 2019-09-10
10344085 Anti-IL-1beta antibodies Peter Michael Huelsmann, Christian Gassner, Sebastian Breuer, Olaf Mundigl, Guy Georges +3 more 2019-07-09
10323089 Anti-transferrin receptor antibodies with tailored affinity Guy Georges, Ulrich Goepfert, Jens Niewoehner, Tilman Schlothauer 2019-06-18